Clinical Trial Update: The Efficacy of the Tailored Therapy Based on Antimicrobial Susceptibility for 2nd Eradication of H. Pylori [NA]

View source ↗

Summary

This completed clinical trial evaluated whether tailoring second-line therapy for Helicobacter pylori based on antimicrobial susceptibility improves eradication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Helicobacter Infection | NA | Status: COMPLETED | Results posted: 2016-10-04